Springer Nature
Browse
12876_2017_627_MOESM1_ESM.pptx (1.04 MB)

Additional file 1: Figure S1. of Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts

Download (1.04 MB)
presentation
posted on 2017-06-07, 05:00 authored by Jun Koo, Myeong-Ok Nam, Younshin Jung, Jongman Yoo, Duk Kim, Gwangil Kim, Sung Shin, Kee Lee, Ki Hahm, Jong Kim, Sung Hong, Kwang Lee, Jun Yoo
Effect of troglitazone (TRG) on TGF-β1-induced expression of α-smooth muscle actin (α-SMA) in human primary intestinal myofibroblasts (HIFs). HIFs on chamber slides were treated with TGF-β1 (5 ng/ml), TRG (20 and 25 μM) for 24 h and then stained with α-SMA antibodies and counterstained with Hoechst. (PPTX 1065 kb)

Funding

Korea Health Industry Development Institute

History

Usage metrics

    BMC Gastroenterology

    Categories

    Keywords

    Inflammatory bowel diseaseIntestinal fibrosisMyofibroblastsTroglitazone (TRG)Rosiglitazone (RSG)Extracellular matrix (ECM)

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC